Pricing Log in Create free account

BioLineRx Ltd. (BLRX) vs Theriva Biologics, Inc. (TOVX)

BioLineRx Ltd. and Theriva Biologics, Inc. are both Biotechnology companies. BioLineRx Ltd. and Theriva Biologics, Inc. are of similar size ($10.2M and $9.7M). BioLineRx Ltd. has negative trailing earnings, so its P/E is not meaningful; Theriva Biologics, Inc. trades at 0.1×. Theriva Biologics, Inc. has the higher net margin (0.00% vs −502.1%) and the lower return on invested capital (−301.7% vs −74.3%). Across the 14 metrics below, BioLineRx Ltd. leads on 8 and Theriva Biologics, Inc. on 6.

Valuation

Metric BLRX TOVX Biotechnology median
P/E n/m 0.15 8.50
P/S 6.51 n/m 9.71
P/B 0.55 0.79 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m 0.01 0.64
EV/Sales 1.93 n/m 9.21
Earnings yield (82.84%) 672.90% (33.15%)
Free cash flow yield (119.61%) (132.61%) (25.50%)

Profitability

Metric BLRX TOVX Biotechnology median
Gross margin 80.03% 0.00% 65.16%
Operating margin (874.28%) 0.00% 0.00%
Net margin (502.08%) 0.00% 0.00%
Free cash flow margin (776.29%) 0.00% 0.00%
Return on equity (38.10%) (115.11%) (56.36%)
Return on assets (18.21%) (37.14%) (48.04%)
Return on invested capital (74.28%) (301.72%) 0.00%

Growth

Metric BLRX TOVX Biotechnology median
Revenue growth (TTM) (91.93%) — 6.02%
EPS growth (last fiscal year) 93.72% 89.07% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BLRX TOVX Biotechnology median
Debt to equity 0.40 0.13 0.00
Current ratio 1.20 1.13 4.72
Net debt to EBITDA 1.22 0.48 0.96

Dividend

Metric BLRX TOVX Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric BLRX TOVX Biotechnology median
Market cap 10.21m 9.73m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack